BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27626069)

  • 1. Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia.
    Bochtler T; Fröhling S; Weichert W; Endris V; Thiede C; Hutter B; Hundemer M; Ho AD; Krämer A
    Cold Spring Harb Mol Case Stud; 2016 Sep; 2(5):a001123. PubMed ID: 27626069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].
    Xue MX; Qiu HY; Feng YF; Zhu ZL; Chang WR; Liang JY; Chen SN; Cen JN; Xue YQ; Liu YJ; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):757-61. PubMed ID: 19176014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
    Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
    Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningeal relapse in a patient with acute promyelocytic leukemia: a case report and review of the literature.
    Bae SH; Ryoo HM; Cho HS; Lee JL; Lee KH; Hyun MS
    J Korean Med Sci; 2004 Apr; 19(2):311-4. PubMed ID: 15082912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of arsenic trioxide in induction therapy improves survival of patients with newly diagnosed acute promyelocytic leukaemia.
    Song X; Hu X; Lü S; Gao L; Chen L; Yang J; Zhang W; Wang J
    Eur J Haematol; 2014 Jul; 93(1):54-62. PubMed ID: 24592821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in a patient with acute promyelocytic leukemia with isolated meningeal relapse.
    Kim SH; Yun J; Kim HJ; Kim CK; Park SK; Hong DS
    Korean J Hematol; 2010 Sep; 45(3):208-10. PubMed ID: 21120212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute promyelocytic leukemia with Flt3-TKD and WT1 mutations relapsing in a testicle and followed by systemic relapse.
    Zou XL; Zeng K; Xie LP; Wang L; Chen M; Liu T; Niu T
    Acta Haematol; 2013; 130(4):223-9. PubMed ID: 23816818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.
    Burry LD; Seki JT
    Ann Pharmacother; 2002 Dec; 36(12):1900-6. PubMed ID: 12452754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gilteritinib Monotherapy as a Transplant Bridging Option for a Patient with
    Kobayashi H; Tsutsumi H; Misaki Y; Maekawa T; Inoshita N; Kawamura M; Maseki N
    Case Rep Hematol; 2023; 2023():8568587. PubMed ID: 38124780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FLT3 mutation in acute promyelocytic leukemia patients with extramedullary relapse].
    Liu J; Zou XL; Liu TT; Jiang M; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):670-4. PubMed ID: 25286697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable outcome of
    Bafail MA; AlTahan R; Samman MA; Tashkandi SA; Motabi IH; Peer-Zada AA
    Clin Case Rep; 2023 Jul; 11(7):e07637. PubMed ID: 37426684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLT3-TKD mutation in childhood acute myeloid leukemia.
    Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Wang LY; Chang WH
    Leukemia; 2003 May; 17(5):883-6. PubMed ID: 12750701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of point mutation at second tyrosine kinase domain of FLT3 gene in acute myeloid leukemia].
    Wang LH; Wang M; Zhou CL; Chen S; Zhang XW; Xing HY; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):335-8. PubMed ID: 16185475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure.
    Gallagher RE; Schachter-Tokarz EL; Zhou DC; Ding W; Kim SH; Sankoorikal BJ; Bi W; Livak KJ; Slack JL; Willman CL
    Leukemia; 2006 Apr; 20(4):556-62. PubMed ID: 16437139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U; Lo-Coco F
    Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel three-way variant t(6;17;15)(p21;q21;q22) in acute promyelocytic leukemia with an FLT3-ITD mutation: A case report.
    Zhang YL; Jiang M; Luan SQ; Liu SY; Wan JH; Wan LG; Zhang ZL
    Oncol Lett; 2018 Nov; 16(5):6121-6125. PubMed ID: 30344754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
    Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
    Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
    Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.